Showing results (201-210 of 328) with videos related to
Sort By:
Pageof 33
Science (New York, N.Y.)|June 27, 1975
HL-A LD (lymphocyte defined) typing: a rapid assay with primed lymphocytesM J Sheehy, P M Sondel, M L Bach, et al.Transplantation|November 24, 1998
Regulated and endothelial cell-specific expression of Fas ligand: an in vitro model for a strategy aiming at inhibiting xenograft rejectionT H Tran, S Grey, J Anrather, et al.Transplantation|December 1, 1993
In vivo depletion of xenoreactive natural antibodies with an anti-mu monoclonal antibodyM P Soares, D Latinne, M Elsen, et al.Transplantation|November 1, 1990
Endothelial cell antigens recognized by xenoreactive human natural antibodiesJ L Platt, B J Lindman, H Chen, et al.Transplantation|March 15, 1996
Direct activation of porcine endothelial cells by human natural killer cellsD J Goodman, M Von Albertini, A Willson, et al.Cancer Research|February 15, 1989
Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsetsA C Ochoa, D E Hasz, R Rezonzew, et al.Transactions of the Association of American Physicians|January 1, 1987
Lymphokine activated killer (LAK) cell-mediated endothelial injury: a mechanism for capillary leak syndrome in patients treated with LAK cells and interleukin-2D Kotasek, G M Vercellotti, A C Ochoa, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1979
Human transfer factors: structural properties suggested by HPRP chromatography and enzymatic sensitivitiesD R Burger, A A Vandenbark, W Dunnick, et al.Scandinavian Journal of Immunology|January 1, 1977
Lack of restimulation by non-HLA antigens in primed lymphocyte typingC Y Shih, E A Valentine, M J Sheehy, et al.Archives of Otolaryngology--Head & Neck Surgery|May 1, 1992
Administration of a prostaglandin synthetase inhibitor associated with an increased immune cell infiltrate in squamous cell carcinoma of the head and neckD S Cross, J L Platt, S K Juhn, et al.Pageof 33